IMMU-15. QUANTIFYING INTRATHECAL DRUG DELIVERY UTILIZING PROGRAMMABLE VENTRICULOPERITONEAL SHUNTS

BACKGROUND: Programmable ventriculoperitoneal (pVP) shunts are increasingly utilized for intraventricular chemotherapy, radioimmunotherapy, and/or cellular therapy. Shunt adjustments allow optimization of thecal space drug concentrations with minimization in the peritoneum. Drug delivery quantificat...

Descripción completa

Detalles Bibliográficos
Autores principales: McThenia, Sheila, Pandit-Taskar, Neeta, Grkovski, Milan, Donzelli, Maria, Diagana, Safiatu, Greenfield, Jeffrey, Souweidane, Mark, Kramer, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Immunology/Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168261/
http://dx.doi.org/10.1093/neuonc/noab090.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168261/
http://dx.doi.org/10.1093/neuonc/noab090.122

Ejemplares similares